Nanotherapeutics or Nanomedicines can improve drug solubility by providing hydrophilic and hydrophobic environments, protect the payload from premature degradation by functioning as a sustained release systems thereby reducing dosing frequencies, control the rate of drug release. Plenty of micro/nano based formulations have been reported so far in metabolic disorders and many have gone into clinical trials. some of the significant formulations are Conjugates, Micelles, Dendrimer, Lipid nanosuspension, Nanostructured lipid carrier, Solid Lipid Nanoparticles, Liposomes.
Autorentext
Dr. Vivek Dwivedi, is an academician and researcher in pharmaceutical sciences with more than 11 years of teaching and research experience. He is working as Associate Professor at Chandra Shekhar Singh College of Pharmacy, Kaushambi. He earned his B. Pharm. degree in 2011 from Maharana Pratap College of Pharmacy, Kanpur, followed by an M. Pharm. in Pharmacology from G.L.A. University, Mathura, in 2013. He is a Ph.D. in Pharmaceutical Sciences at the Department of Pharmaceutical Sciences, Shalom Institute of Health & Allied Sciences (SIHAS), Sam Higginbottom University of Agriculture, Technology & Sciences (SHUATS), Prayagraj.
His professional journey includes serving as Assistant Professor at Shambhunath Institute of Pharmacy, Allahabad, for five years, and since 2018. His academic and research expertise lies in pharmacology, natural product research, molecular modeling, and nanotechnology-based drug delivery systems.
Dr. Dwivedi has authored and co-authored several research papers, book chapters, and reviews published in reputed national and international journals. His research contributions encompass anti-ulcer pharmacology, QSAR modeling, anticancer drug development, antibacterial agents, and phytopharmacological studies. He has also presented his work at numerous conferences, faculty development programs, and workshops across India.
With industrial training experience at Brawn Laboratories, Faridabad, and technical proficiency in advanced instruments and molecular modeling software, he continues to integrate research with teaching. He remains dedicated to advancing pharmaceutical sciences and mentoring the next generation of professionals.